Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Killer Cells, Natural | 13 | 2023 | 2170 | 1.790 |
Why?
|
Immunotherapy, Adoptive | 4 | 2020 | 1392 | 0.790 |
Why?
|
Leukemia, Prolymphocytic, T-Cell | 1 | 2019 | 23 | 0.680 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2019 | 83 | 0.680 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2021 | 209 | 0.670 |
Why?
|
Interleukin-15 | 4 | 2023 | 181 | 0.490 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1793 | 0.380 |
Why?
|
Myeloid Progenitor Cells | 1 | 2010 | 113 | 0.360 |
Why?
|
Receptors, Immunologic | 2 | 2006 | 1415 | 0.310 |
Why?
|
Hematologic Neoplasms | 1 | 2019 | 1837 | 0.290 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2019 | 3539 | 0.270 |
Why?
|
Cell Differentiation | 5 | 2019 | 11385 | 0.230 |
Why?
|
Receptors, KIR3DL1 | 2 | 2019 | 27 | 0.220 |
Why?
|
Flow Cytometry | 4 | 2022 | 5837 | 0.210 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5689 | 0.200 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2023 | 1377 | 0.200 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2021 | 88 | 0.200 |
Why?
|
Immunophenotyping | 3 | 2022 | 1854 | 0.190 |
Why?
|
Toxoplasmosis | 1 | 2021 | 91 | 0.180 |
Why?
|
Leukemia | 1 | 2008 | 1500 | 0.180 |
Why?
|
Ki-67 Antigen | 1 | 2002 | 635 | 0.180 |
Why?
|
Toxoplasma | 1 | 2021 | 149 | 0.180 |
Why?
|
Immunoblastic Lymphadenopathy | 2 | 2017 | 40 | 0.170 |
Why?
|
Receptors, KIR2DL2 | 1 | 2019 | 9 | 0.170 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2021 | 4296 | 0.170 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2021 | 1509 | 0.170 |
Why?
|
HLA-C Antigens | 1 | 2019 | 150 | 0.160 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2020 | 1392 | 0.160 |
Why?
|
HLA-B Antigens | 1 | 2019 | 351 | 0.150 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 261 | 0.150 |
Why?
|
HLA Antigens | 3 | 2009 | 1340 | 0.140 |
Why?
|
Antigens, CD19 | 2 | 2020 | 410 | 0.140 |
Why?
|
Central Nervous System Viral Diseases | 1 | 2016 | 40 | 0.140 |
Why?
|
Lymphoid Tissue | 1 | 2018 | 448 | 0.140 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2017 | 124 | 0.130 |
Why?
|
Stromal Cells | 3 | 2010 | 1304 | 0.120 |
Why?
|
Immunotherapy | 2 | 2023 | 4594 | 0.120 |
Why?
|
Lymphoma, Follicular | 1 | 2019 | 446 | 0.120 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2016 | 236 | 0.120 |
Why?
|
Diphtheria Toxin | 1 | 2015 | 252 | 0.120 |
Why?
|
Hematopoietic Stem Cells | 1 | 2006 | 3345 | 0.110 |
Why?
|
Bone Marrow | 3 | 2021 | 2901 | 0.110 |
Why?
|
Lymphoma, T-Cell | 1 | 2016 | 302 | 0.110 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2412 | 0.100 |
Why?
|
Coculture Techniques | 3 | 2020 | 1327 | 0.100 |
Why?
|
K562 Cells | 2 | 2010 | 643 | 0.100 |
Why?
|
Herpesvirus 4, Human | 1 | 2016 | 1065 | 0.090 |
Why?
|
Antigens, CD | 3 | 2019 | 3898 | 0.090 |
Why?
|
Receptors, KIR | 2 | 2019 | 113 | 0.090 |
Why?
|
Monocytes | 1 | 2020 | 2544 | 0.090 |
Why?
|
Colony-Forming Units Assay | 1 | 2010 | 352 | 0.090 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2016 | 597 | 0.090 |
Why?
|
Lymph Nodes | 1 | 2022 | 3446 | 0.090 |
Why?
|
Myelodysplastic Syndromes | 1 | 2020 | 1357 | 0.090 |
Why?
|
Immunohistochemistry | 3 | 2022 | 11037 | 0.090 |
Why?
|
Mesenchymal Stem Cells | 1 | 2020 | 1613 | 0.080 |
Why?
|
Natural Cytotoxicity Triggering Receptor 3 | 1 | 2008 | 14 | 0.080 |
Why?
|
Leukemia, Experimental | 1 | 2009 | 224 | 0.080 |
Why?
|
Antigens, CD34 | 1 | 2010 | 630 | 0.080 |
Why?
|
Graft vs Host Reaction | 1 | 2008 | 103 | 0.080 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2008 | 324 | 0.080 |
Why?
|
Central Nervous System Neoplasms | 1 | 2016 | 889 | 0.080 |
Why?
|
Humans | 27 | 2023 | 746070 | 0.080 |
Why?
|
Histocompatibility Testing | 1 | 2009 | 695 | 0.080 |
Why?
|
Self Tolerance | 1 | 2008 | 121 | 0.080 |
Why?
|
Antibodies | 1 | 2015 | 2408 | 0.070 |
Why?
|
Cell Count | 1 | 2010 | 1831 | 0.070 |
Why?
|
Organ Transplantation | 1 | 2016 | 1130 | 0.070 |
Why?
|
B-Lymphocytes | 2 | 2016 | 4671 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2016 | 2887 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2023 | 4846 | 0.070 |
Why?
|
Lymphocyte Subsets | 1 | 2007 | 309 | 0.070 |
Why?
|
Vaccination | 1 | 2018 | 3282 | 0.070 |
Why?
|
Adoptive Transfer | 1 | 2008 | 788 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4518 | 0.070 |
Why?
|
Major Histocompatibility Complex | 1 | 2008 | 916 | 0.060 |
Why?
|
Natural Killer T-Cells | 1 | 2008 | 310 | 0.060 |
Why?
|
Fetal Blood | 2 | 2009 | 1318 | 0.060 |
Why?
|
Cyclosporine | 1 | 2007 | 751 | 0.060 |
Why?
|
Young Adult | 6 | 2022 | 57114 | 0.060 |
Why?
|
Receptors, IgG | 1 | 2007 | 566 | 0.060 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1624 | 0.060 |
Why?
|
Antigens, Differentiation | 1 | 2006 | 846 | 0.060 |
Why?
|
Transplantation, Homologous | 2 | 2009 | 4617 | 0.060 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2009 | 1338 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5465 | 0.050 |
Why?
|
Receptors, KIR2DL1 | 1 | 2002 | 16 | 0.050 |
Why?
|
Hydrocortisone | 1 | 2010 | 1776 | 0.050 |
Why?
|
Disease Progression | 1 | 2019 | 13302 | 0.050 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2002 | 488 | 0.050 |
Why?
|
Embryonic Stem Cells | 1 | 2009 | 1265 | 0.050 |
Why?
|
Up-Regulation | 1 | 2010 | 4115 | 0.050 |
Why?
|
Niacinamide | 1 | 2023 | 412 | 0.050 |
Why?
|
Adolescent | 5 | 2022 | 86212 | 0.050 |
Why?
|
Aged | 8 | 2021 | 164222 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2010 | 18891 | 0.040 |
Why?
|
Middle Aged | 9 | 2022 | 214419 | 0.040 |
Why?
|
Graft vs Host Disease | 2 | 2009 | 2931 | 0.040 |
Why?
|
Child, Preschool | 2 | 2021 | 41383 | 0.040 |
Why?
|
Adult | 9 | 2022 | 214969 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2022 | 78293 | 0.040 |
Why?
|
Yellow Fever Vaccine | 1 | 2018 | 37 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2019 | 38752 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2008 | 4276 | 0.040 |
Why?
|
Clonal Anergy | 1 | 2018 | 168 | 0.040 |
Why?
|
HIV Seronegativity | 1 | 2018 | 208 | 0.040 |
Why?
|
Biopsy | 2 | 2021 | 6732 | 0.040 |
Why?
|
Chemokine CXCL13 | 1 | 2017 | 59 | 0.040 |
Why?
|
HIV Infections | 2 | 2020 | 16937 | 0.030 |
Why?
|
Child | 3 | 2021 | 78469 | 0.030 |
Why?
|
Eye Proteins | 1 | 2020 | 627 | 0.030 |
Why?
|
Minnesota | 1 | 2016 | 336 | 0.030 |
Why?
|
Male | 9 | 2021 | 351098 | 0.030 |
Why?
|
Female | 9 | 2023 | 382129 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2002 | 1868 | 0.030 |
Why?
|
Splenomegaly | 1 | 2016 | 188 | 0.030 |
Why?
|
Ligands | 1 | 2002 | 3266 | 0.030 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2017 | 167 | 0.030 |
Why?
|
Immunotoxins | 1 | 2015 | 178 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2020 | 1131 | 0.030 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2015 | 98 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2007 | 4055 | 0.030 |
Why?
|
Neuropeptides | 1 | 2020 | 941 | 0.030 |
Why?
|
Gene Silencing | 1 | 2020 | 1511 | 0.030 |
Why?
|
Uganda | 1 | 2018 | 1296 | 0.030 |
Why?
|
Lymphocyte Activation | 2 | 2018 | 5414 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2018 | 722 | 0.030 |
Why?
|
In Situ Hybridization | 1 | 2016 | 1900 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2015 | 870 | 0.030 |
Why?
|
T-Lymphocytes | 2 | 2016 | 10018 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2020 | 2063 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2020 | 1945 | 0.030 |
Why?
|
Cell Line | 1 | 2006 | 15630 | 0.030 |
Why?
|
Mice | 4 | 2023 | 80065 | 0.020 |
Why?
|
Microvessels | 1 | 2016 | 567 | 0.020 |
Why?
|
Mutation | 1 | 2016 | 29620 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2020 | 2511 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2016 | 983 | 0.020 |
Why?
|
Fibrosis | 1 | 2018 | 2005 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2008 | 11842 | 0.020 |
Why?
|
Animals | 5 | 2023 | 166308 | 0.020 |
Why?
|
Collagen | 1 | 2018 | 2616 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2856 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2018 | 2215 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3533 | 0.020 |
Why?
|
Cytokines | 2 | 2018 | 7219 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3610 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2018 | 1896 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2020 | 57552 | 0.020 |
Why?
|
RNA, Viral | 1 | 2016 | 2818 | 0.020 |
Why?
|
Cell Degranulation | 1 | 2008 | 277 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4119 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8509 | 0.020 |
Why?
|
DNA | 1 | 2021 | 7199 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8373 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2018 | 3075 | 0.020 |
Why?
|
Graft vs Leukemia Effect | 1 | 2007 | 119 | 0.020 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2007 | 194 | 0.020 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2007 | 429 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2007 | 463 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5746 | 0.020 |
Why?
|
NFATC Transcription Factors | 1 | 2007 | 378 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2009 | 1809 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11064 | 0.010 |
Why?
|
Genotype | 1 | 2019 | 12775 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12272 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 5164 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9313 | 0.010 |
Why?
|
Mice, SCID | 1 | 2009 | 2620 | 0.010 |
Why?
|
Models, Biological | 1 | 2020 | 9443 | 0.010 |
Why?
|
Cell Separation | 1 | 2008 | 1718 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10719 | 0.010 |
Why?
|
Calcium Signaling | 1 | 2007 | 720 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 21676 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15010 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2008 | 3134 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16250 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2007 | 2901 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17435 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2009 | 4247 | 0.010 |
Why?
|
Apoptosis | 1 | 2008 | 9425 | 0.010 |
Why?
|
Prospective Studies | 1 | 2017 | 53219 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 63664 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2009 | 4271 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2008 | 16652 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2007 | 10303 | 0.010 |
Why?
|
United States | 1 | 2017 | 70368 | 0.010 |
Why?
|
Time Factors | 1 | 2007 | 39589 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 2009 | 13196 | 0.000 |
Why?
|
Risk Factors | 1 | 2009 | 72413 | 0.000 |
Why?
|